The startup's models read clinician notes nightly and push a risk score into the EHR by morning, and it now…
Multiply Labs says its robotic clusters cut cost per dose by 74% and lift throughput 100-fold over manual biologics production.
A Zuckerberg-founded nonprofit is assembling $1.8B for open biological AI data, backed by $300M from three tech partners and $500M…
Alphabet's AI drug discovery spinout is back in the market less than five months after a $2.1 billion round.
An AI search over excipient blends kept mRNA vaccines potent for months at high heat, a step toward freeing clinical…
Red Queen Bio has raised $36M to build AI-designed antibody drugs fast enough to outrun whatever frontier models might enable.
HITS, the KAIST spinout, has raised $13.4M to put AI agents that search literature, analyze data and test hypotheses into…
The Australian biotech will use Amazon's cloud and AI tools across discovery and clinical development, from target hunting to regulatory…